Lonza | LONN - Cost Of Sales

Stock Price
536.20
Daily Change
4.20 0.79%
Monthly
-1.94%
Yearly
-5.70%
Q1 Forecast
523.37

Lonza reported CHF2.28B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akzo Nobel EUR 1.44B 84M Dec/2025
Alcon AG USD 1.16B 52M Sep/2025
Almirall EUR 191.5M 2.29M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
BASF EUR 10.93B 241M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Beiersdorf EUR 2.11B 130M Jun/2025
Covestro EUR -2.68B 5.51B Sep/2025
Demant DKK 2.89B 188M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Geberit CHF 252.6M 6.3M Sep/2025
Genmab DKK 57M 15M Jun/2025
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GN Store Nord DKK 2.24B 338M Dec/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Johnson Matthey GBP 5.04B 513M Dec/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Philips EUR 2.81B 417M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Sika AG CHF 2.82B 195.2M Jun/2025
Smith & Nephew USD 870M 17M Dec/2025
Solvay EUR 860M 71M Dec/2025
UCB EUR 901M 50M Dec/2024